136 related articles for article (PubMed ID: 25450272)
1. Serum bone-specific alkaline phosphatase as a biomarker for osseous metastases in patients with malignant carcinomas: a systematic review and meta-analysis.
Du WX; Duan SF; Chen JJ; Huang JF; Yin LM; Tong PJ
J Cancer Res Ther; 2014 Nov; 10 Suppl():C140-3. PubMed ID: 25450272
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.
Wei RJ; Li TY; Yang XC; Jia N; Yang XL; Song HB
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323113
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of alkaline phosphatase and bone-specific alkaline phosphatase for metastases in breast cancer: a systematic review and meta-analysis.
Jiang C; Hu F; Li J; Gao G; Guo X
Breast Cancer Res Treat; 2023 Nov; 202(2):233-244. PubMed ID: 37522998
[TBL] [Abstract][Full Text] [Related]
4. Serum alkaline phosphatase isoenzyme activities in canine malignant mammary neoplasms with and without osseous transformation.
Karayannopoulou M; Polizopoulou ZS; Koutinas AF; Fytianou A; Roubies N; Kaldrymidou E; Tsioli V; Patsikas MN; Constantinidis TC; Koutinas CK
Vet Clin Pathol; 2006 Sep; 35(3):287-90. PubMed ID: 16967410
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of osseous metastases of malignant tumors by bone scanning combined with bone alkaline phosphatase detection].
Fan YX; Luo RC; Li GP; Huang K
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):812-4. PubMed ID: 15257911
[TBL] [Abstract][Full Text] [Related]
6. Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.
Huang P; Lan M; Peng AF; Yu QF; Chen WZ; Liu ZL; Liu JM; Huang SH
PLoS One; 2017; 12(9):e0183835. PubMed ID: 28902911
[TBL] [Abstract][Full Text] [Related]
7. Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
Zulauf N; Brüggmann D; Groneberg D; Oremek GM
Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
[TBL] [Abstract][Full Text] [Related]
8. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
[TBL] [Abstract][Full Text] [Related]
9. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
10. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
Wang ZL; Wang XF
Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
[TBL] [Abstract][Full Text] [Related]
11. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma.
Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI
Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412
[TBL] [Abstract][Full Text] [Related]
12. Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer.
Jung K; Stephan C; Semjonow A; Lein M; Schnorr D; Loening SA
J Urol; 2003 Dec; 170(6 Pt 1):2302-5. PubMed ID: 14634401
[TBL] [Abstract][Full Text] [Related]
13. Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.
Lim SM; Kim YN; Park KH; Kang B; Chon HJ; Kim C; Kim JH; Rha SY
BMC Cancer; 2016 Jul; 16():385. PubMed ID: 27377907
[TBL] [Abstract][Full Text] [Related]
14. Plasma acid and alkaline phosphatase in patients with breast cancer.
Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
[TBL] [Abstract][Full Text] [Related]
15. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.
Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP
Oncology; 1996; 53(4):275-80. PubMed ID: 8692530
[TBL] [Abstract][Full Text] [Related]
16. A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents.
Shimose S; Kubo T; Fujimori J; Furuta T; Ochi M
J Orthop Sci; 2014 Nov; 19(6):997-1003. PubMed ID: 25100572
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
Casetta G; Gamba P; Piana P; Pecchio F; Tizzani A
Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
[TBL] [Abstract][Full Text] [Related]
18. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer.
Huang J; Gu T; Ying J
Int J Clin Oncol; 2017 Dec; 22(6):1015-1025. PubMed ID: 28677013
[TBL] [Abstract][Full Text] [Related]
20. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]